BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sterling J, Menezes SV, Abbassi RH, Munoz L. Histone lysine demethylases and their functions in cancer. Int J Cancer 2021;148:2375-88. [DOI: 10.1002/ijc.33375] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen LJ, Xu XY, Zhong XD, Liu YJ, Zhu MH, Tao F, Li CY, She QS, Yang GJ, Chen J. The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy. Bioorg Chem 2023;133:106409. [PMID: 36753963 DOI: 10.1016/j.bioorg.2023.106409] [Reference Citation Analysis]
2 Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct Target Ther 2023;8:69. [PMID: 36797239 DOI: 10.1038/s41392-023-01341-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang W, Wu F, Mohammadniaei M, Zhang M, Li Y, Sun Y, Tang BZ. Genetically edited T-cell membrane coated AIEgen nanoparticles effectively prevents glioblastoma recurrence. Biomaterials 2023;293:121981. [PMID: 36580721 DOI: 10.1016/j.biomaterials.2022.121981] [Reference Citation Analysis]
4 Pinton G, Boumya S, Ciriolo MR, Ciccarone F. Epigenetic Insights on PARP-1 Activity in Cancer Therapy. Cancers (Basel) 2022;15. [PMID: 36612003 DOI: 10.3390/cancers15010006] [Reference Citation Analysis]
5 Fu J, Han Z, Wu Z, Xia Y, Yang G, Yin Y, Ren W. GABA regulates IL-1β production in macrophages. Cell Rep 2022;41:111770. [PMID: 36476877 DOI: 10.1016/j.celrep.2022.111770] [Reference Citation Analysis]
6 Pan F, Huang K, Dai H, Sha C. PHF8 promotes osteogenic differentiation of BMSCs in old rat with osteoporosis by regulating Wnt/β-catenin pathway. Open Life Sciences 2022;17:1591-1599. [DOI: 10.1515/biol-2022-0523] [Reference Citation Analysis]
7 Shishido K, Reinders A, Asuthkar S. Epigenetic regulation of radioresistance: insights from preclinical and clinical studies. Expert Opin Investig Drugs 2022;31:1359-75. [PMID: 36524403 DOI: 10.1080/13543784.2022.2158810] [Reference Citation Analysis]
8 Zhao P, Malik S. The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes. Cell Biosci 2022;12:83. [DOI: 10.1186/s13578-022-00821-7] [Reference Citation Analysis]
9 Zhai L, Chen K, Hao B, Tan M. Proteomic characterization of post-translational modifications in drug discovery. Acta Pharmacol Sin 2022. [DOI: 10.1038/s41401-022-01017-y] [Reference Citation Analysis]
10 Yang Z, Lu W, Qi Z, Yang X. Identification of hub genes regulating the cell activity and function of adipose-derived stem cells under oxygen-glucose deprivation. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.1025690] [Reference Citation Analysis]
11 Li X, Feng C, Peng S. Epigenetics alternation in lung fibrosis and lung cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1060201] [Reference Citation Analysis]
12 Lin GH, Wu SH, Ko YC, Lin CH, Liao GS, Chen TW, Chen YJ, Hsu KF. Comprehensive Analyses of Prognostic Values and Immune Infiltration of KDM3 Gene Family in Hepatocellular Carcinoma. Mol Biotechnol 2022. [PMID: 36181608 DOI: 10.1007/s12033-022-00568-z] [Reference Citation Analysis]
13 Qu L, Fang Q, Yin T, Yi H, Mei G, Hong Z, Qiu X, Zhou R, Dong H. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma. Cancer Immunol Immunother 2022;71:2449-2467. [DOI: 10.1007/s00262-022-03167-8] [Reference Citation Analysis]
14 Wang T, Yang W, Liu Y, Li W, Wang Y, Liu N, Sheng C. Jumonji Histone Demethylase Inhibitor JIB-04 as a Broad-Spectrum Antifungal Agent. ACS Infect Dis 2022. [PMID: 35695031 DOI: 10.1021/acsinfecdis.2c00096] [Reference Citation Analysis]
15 Liu C, Zhou X, Jin J, Zhu Q, Li L, Yin Q, Xu T, Gu W, Ma F, Yang R. The Association Between Breast Cancer and Blood-Based Methylation of CD160, ISYNA1 and RAD51B in the Chinese Population. Front Genet 2022;13:927519. [DOI: 10.3389/fgene.2022.927519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 del Moral-morales A, Salgado-albarrán M, Ortiz-gutiérrez E, Pérez-hernández G, Soto-reyes E. Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in Cancer. Front Genet 2022;13:860924. [DOI: 10.3389/fgene.2022.860924] [Reference Citation Analysis]
17 Fioravanti R, Rodriguez V, Caroli J, Chianese U, Benedetti R, Di Bello E, Noce B, Zwergel C, Corinti D, Viña D, Altucci L, Mattevi A, Valente S, Mai A. Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity. J Enzyme Inhib Med Chem 2022;37:973-85. [PMID: 35317680 DOI: 10.1080/14756366.2022.2052869] [Reference Citation Analysis]
18 Jayanthi S, McCoy MT, Cadet JL. Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder. Genes (Basel) 2021;12:1614. [PMID: 34681009 DOI: 10.3390/genes12101614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Duan YC, Zhang SJ, Shi XJ, Jin LF, Yu T, Song Y, Guan YY. Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy. Eur J Med Chem 2021;222:113588. [PMID: 34107385 DOI: 10.1016/j.ejmech.2021.113588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]